Bio-Rad touts sales increases for Q2

By The Science Advisory Board staff writers

July 30, 2021 -- Bio-Rad Laboratories announced sales increases in its second-quarter financial results for 2021 (end-June 30).

The company said that life science segment net sales for the quarter were $334.2 million, an increase of 32.6% compared to the same quarter in 2020. Clinical diagnostics segment sales meanwhile were $380.2 million, an increase of 34.3% compared to the same period last year.

Overall net sales for the quarter were $715.9 million, an increase of 33.4% compared to $536.9 million reported for the second quarter of 2020.

Company leaders said the performance for both areas was ahead of expectations.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.